CAFENOL

This brand name is authorized in Nigeria. It is also authorized in Tunisia.

Active ingredients

The drug CAFENOL contains a combination of these active pharmaceutical ingredients (APIs):

1	Acetylsalicylic acid UNII R16CO5Y76E - ASPIRIN
	Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs.
	Read more about Acetylsalicylic acid
2	Caffeine UNII 3G6A5W338E - CAFFEINE
	Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant.
	Read more about Caffeine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-0023	Tablet	Cafenol TAB 375 mg; 25 mg 8 X 20	53 RNW-PP-318896 Cafenol Caffeine 25mg and Acetylsalicylic acid 375mg Acetylsalicylic granules 25mg, Acetylsalicylic crystals 149.9mg, Maize starch 41.2mg 04-0023 Drugs Imported Products 820 Over The Counter (OTC) 5/11/2023 ASPEN PHARMACARE NIGERIA LIMITED, plot 28,infinty house,ilupeju bypass 9062496814 dadeduro@ng.aspenpharma.com BETA HEALTHCARE INTERNATIONAL LTD, PLOT NO: LR 209/ 6554 MOGADISHU RD, INDUSTRIAL AREA, P.O. BOX 42569-00100 NAIROBI, KENYA, Kenya	31/01/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02BA51	Acetylsalicylic acid, combinations excl. psycholeptics	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BA Salicylic acid and derivatives
Discover more medicines within N02BA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-0023
TN	Direction de la Pharmacie et du Médicament	9253291